Understanding the Critical Differences Between GLP-1 Weight Loss Drugs and Why Thousands Are Filing Lawsuits Last Updated: January 2026 Introduction: Why Understanding These Differences Matters If youre researching GLP-1 weight-loss medications , youve likely encountered confusing brand names: Ozempic, Wegovy, Mounjaro, Zepbound, and others
The higher the energy needs (higher metabolism, exercise, stress, etc.), the harder the mitochondria have to work and the more free radicals they produce
There is no generally accepted treatment for NAION and it can cause bilateral blindness
It continues to be studied for its role in overall wellness
16 The observed association between GLP-1 receptor agonist use and reduced risk of legal blindness may be biologically plausible given their established anti-inflammatory and neuroprotective effects, including modulation of neuroinflammation and preservation of neuronal integrity